Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 1
1982 1
1983 1
1984 1
1993 2
1994 2
1995 2
1996 3
1997 2
1998 2
1999 3
2000 3
2001 7
2002 8
2003 7
2004 13
2005 14
2006 17
2007 10
2008 14
2009 26
2010 34
2011 29
2012 24
2013 26
2014 24
2015 34
2016 30
2017 31
2018 36
2019 17
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

381 results
Results by year
Filters applied: . Clear all
Page 1
Adherence and resource use among psoriasis patients treated with biologics.
Aleshaki JS, Cardwell LA, Muse ME, Feldman SR. Aleshaki JS, et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):609-617. doi: 10.1080/14737167.2018.1512408. Epub 2018 Sep 10. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 30142007 Review.
The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review.
Burgos-Pol R, Martínez-Sesmero JM, Ventura-Cerdá JM, Elías I, Caloto MT, Casado MÁ. Burgos-Pol R, et al. Actas Dermosifiliogr. 2016 Sep;107(7):577-90. doi: 10.1016/j.ad.2016.04.018. Epub 2016 Jun 15. Actas Dermosifiliogr. 2016. PMID: 27316590 Free article. Review. English, Spanish.
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ramaekers BLT, Wolff RF, Pouwels X, Oosterhoff M, Van Giessen A, Worthy G, Noake C, Armstrong N, Kleijnen J, Joore MA. Ramaekers BLT, et al. Pharmacoeconomics. 2018 Aug;36(8):917-927. doi: 10.1007/s40273-018-0629-2. Pharmacoeconomics. 2018. PMID: 29480455 Free PMC article. Review.
Patient preference for biologic treatments of psoriasis in Japan.
Tada Y, Ishii K, Kimura J, Hanada K, Kawaguchi I. Tada Y, et al. J Dermatol. 2019 Jun;46(6):466-477. doi: 10.1111/1346-8138.14870. Epub 2019 Apr 15. J Dermatol. 2019. PMID: 30985030 Free PMC article.
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.
Hendrix N, Ollendorf DA, Chapman RH, Loos A, Liu S, Kumar V, Linder JA, Pearson SD, Veenstra DL. Hendrix N, et al. J Manag Care Spec Pharm. 2018 Dec;24(12):1210-1217. doi: 10.18553/jmcp.2018.24.12.1210. J Manag Care Spec Pharm. 2018. PMID: 30479197 Free article.
381 results
Jump to page
Feedback